Advancing the Science of Study Endpoints

Examine global strategies for selecting study endpoints and the impact of endpoints during the analysis of clinical evidence for various types of drug approval processes.

Back to Agenda

Session 3: Research Presentations

Session Chair(s)

René Allard, PHD

Contractor, CTC, Germany

This session will highlight the scientific contributions of new and upcoming investigators involved in study endpoint development, application and analysis.

Speaker(s)

Jean Paty, PHD, MS

Vice President, Patient-Centered Science, IQVIA, United States

Session Co-Chair

Carolina Beraldo Meloto, DDS, PHD

Human Pain Genetics Lab, Faulty of Dentistry, McGill University, Canada

Predictors of TMD Persistence: Bringing Science into the Clinic

Katherine Zarzar

Head of Agile Execution, Patient-Centered Outcomes Research, Genentech, A Member of the Roche Group, United States

Delivering COA Strategies: Improving Our Understanding of the Patient Experience via High Quality Data

Have an account?